Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer

Carcinogenesis

Volumn 37, Issue 2, 2015, Pages 188-196

  Bodelon, Clara ^a   Vinokurova, Svetlana ^b   Sampson, Joshua N ^a   den Boon, Johan A ^c,d   Walker, Joan L ^e   Horswill, Mark A ^c   Korthauer, Keegan ^f   Schiffman, Mark ^a   Sherman, Mark E ^a   Zuna, Rosemary E ^e   Mitchell, Jason ^a   Zhang, Xijun ^a   Boland, Joseph F ^a   Chaturvedi, Anil K ^a   Dunn, S Terence ^e   Newton, Michael A ^f   Ahlquist, Paul ^c,d   Wang, Sophia S ^g   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BIOPSY; CERVICAL PRECANCER; CHROMOSOMAL INSTABILITY; CHROMOSOME 3; CHROMOSOME 8; COPY NUMBER VARIATION; DNA INTEGRATION; FEMALE; GENOME; GENOMIC INSTABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INVASIVE CERVICAL CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; PRECANCER; PRIORITY JOURNAL; TUMOR INVASION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DOSAGE; GENETICS; LASER CAPTURE MICRODISSECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENOMIC INSTABILITY; HUMAN PAPILLOMAVIRUS 16; HUMANS; LASER CAPTURE MICRODISSECTION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 84961988025     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv171     Document Type: Article

References (44)

1. Schiffman, M. et al. (2007) Human papillomavirus and cervical cancer. Lancet, 370, 890-907.
2. Rodríguez, A.C. et al.; Proyecto Epidemiológico Guanacaste Group. (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl. Cancer Inst., 100, 513-517.
3. Rodríguez, A.C. et al. (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J. Natl. Cancer Inst., 102, 315-324.
4. Bouvard, V. et al.; WHO International Agency for Research on Cancer Monograph Working Group. (2009) A review of human carcinogens-Part B: biological agents. Lancet. Oncol., 10, 321-322.
5. de Sanjose, S. et al.; Retrospective International Survey and HPV Time Trends Study Group. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet. Oncol., 11, 1048-1056.
6. Mantovani, F. et al. (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20, 7874-7887.
7. Münger, K. et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-7898.
8. Korzeniewski, N. et al. (2011) Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett., 305, 113-122.
9. Thomas, L.K. et al. (2014) Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract-a systematic review and meta-analysis. Eur. J. Cancer, 50, 85-98.
10. Klaes, R. et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res., 59, 6132-6136.
11. Wentzensen, N. et al. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene, 21, 419-426.
12. Vinokurova, S. et al. (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res., 68, 307-313.
13. Jeon, S. et al. (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA, 92, 1654-1658.
14. Wentzensen, N. et al. (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res., 64, 3878-3884.
15. Reuter, S. et al. (1998) APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J., 17, 215-222.
16. Schmitz, M. et al. (2012) Loss of gene function as a consequence of human papillomavirus DNA integration. Int. J. Cancer, 131, E593-E602.
17. Melsheimer, P. et al. (2004) DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin. Cancer Res., 10, 3059-3063.
18. Wang, S.S. et al. (2009) Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol. Biomarkers Prev., 18, 113-120.
19. Wentzensen, N. et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int. J. Cancer, 125, 2151-2158.
20. Schiffman, M. et al. (2000) ASCUS-LSIL Triage Study. Acta Cytologica, 44, 726-742.
21. Wang, S.S. et al. (2006) Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlaterfixation. Diagn. Mol. Pathol., 15, 144-148.
22. Dunn, S.T. et al. (2007) DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J. Virol. Methods, 143, 45-54.
23. Sherman, L. et al. (1992) Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int. J. Cancer, 50, 356-364.
24. Luft, F. et al. (2001) Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int. J. Cancer, 92, 9-17.
25. Cullen, M. et al. (2015) Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res., 1, 3-11.
26. Smyth, G.K. et al. (2003) Normalization of cDNA microarray data. Methods, 31, 265-273.
27. Venkatraman, E.S. et al. (2007) A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics, 23, 657-663.
28. van de Wiel, M.A. et al. (2007) CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics, 23, 892-4.
29. Marioni, J.C. et al. (2007) Breaking the waves: improved detection of copy number variation from microarray-based comparative genomic hybridization. Genome Biol., 8, R228.
30. Halper-Stromberg, E. et al. (2011) Performance assessment of copy number microarray platforms using a spike-in experiment. Bioinformatics, 27, 1052-1060.
31. Zack, T.I. et al. (2013) Pan-cancer patterns of somatic copy number alteration. Nat. Genet., 45, 1134-1140.
32. Curtis, C. et al. (2012) The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature, 486, 346-52.
33. The ENCODE Project Consortium (2004) The ENCODE (ENCyclopedia Of DNA Elements) Project. Science, 306, 636-640.
34. Lukusa, T. et al. (2008) Human chromosome fragility. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 1779, 3-16.
35. Song, L. et al. (2011) Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Research, 21, 1757-1767.
36. Bierkens, M. et al. (2012) Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int. J. Cancer, 131, E579-E585.
37. Kraus, I. et al. (2008) The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res., 68, 2514-2522.
38. Schmitz, M. et al. (2012) Non-random integration of the HPV genome in cervical cancer. PLoS One, 7, e39632.
39. Xu, B. et al. (2013) Multiplex identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLoS One, 8, e66693.
40. Peter, M. et al. (2010) Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J. Pathol., 221, 320-330.
41. Ojesina, A.I. et al. (2014) Landscape of genomic alterations in cervical carcinomas. Nature, 506, 371-375.
42. Duensing, S. et al. (2004) Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene, 23, 8206-8215.
43. Han, T. et al. (2012) Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development. BMC Genomics, 13, 217.
44. Przybytkowski, E. et al. (2011) The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome. BMC Med. Genomics, 4, 16.